Table 1– Experimental protocols utilised in this study
GroupsPBS s.c.OVA s.c.PBS i.p.CO i.p.NA i.p.ETX i.n.
PBS/CO+--+--
PBS/NA+--++-
OVA/CO-+-+--
OVA/NA-+-++-
PBS/PBS+-+---
PBS/OVA-++---
OVA/CO/ETX-+-+-+
OVA/NA/ETX-+-+++

  • Groups included mice that were either sham-sensitised with PBS or ovalbumin (OVA)-sensitised, and treated with solvent corn oil (CO) only or with naphthalene (NA) dissolved in CO. Additional groups included OVA-sensitised, CO- or NA-treated mice that received a single dose of intranasal eotaxin (ETX; 4 μg) on the first day of challenge. s.c.: subcutaneous; i.p.: intraperitoneal; i.n.: intranasal. +: treated with; -: excluded.